ArticleMembranes2026
Second-Pass Vessel Arrangement and Separation-Limited Operation in Two-Pass Seawater Reverse Osmosis Under Progressive Fouling: Implications for Electrolytic Hydrogen Production.
Article in Membranes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Seawater reverse osmosis (SWRO) supplies the purification chain of electrolytic hydrogen plants, yet its long-term behaviour under fouling is rarely resolved at train level. This work presents a dynamic, quasi-steady-state model of a two-pass SWRO train and compares three second-pass architectures under progressive first-pass fouling, represented by time-evolving water- and solute-permeability coefficients. At each of 51 instants over a 500-day horizon, the operating point is re-optimized to minimize specific energy consumption (SEC), subject to a product limit of 20 mg·L
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.